Transgene Biotek reports standalone net loss of Rs 3.99 crore in the March 2017 quarter

Sales decline 25.00% to Rs 0.09 crore

Net Loss of Transgene Biotek reported to Rs 3.99 crore in the quarter ended March 2017 as against net loss of Rs 7.14 crore during the previous quarter ended March 2016. Sales declined 25.00% to Rs 0.09 crore in the quarter ended March 2017 as against Rs 0.12 crore during the previous quarter ended March 2016.

For the full year,net loss reported to Rs 19.63 crore in the year ended March 2017 as against net loss of Rs 21.54 crore during the previous year ended March 2016. Sales declined 8.57% to Rs 0.32 crore in the year ended March 2017 as against Rs 0.35 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales0.090.12 -25 0.320.35 -9 OPM %-2177.78-216.67 --793.75-277.14 - PBDT-1.52-0.26 -485 -2.10-1.04 -102 PBT-3.99-7.14 44 -19.63-21.54 9 NP-3.99-7.14 44 -19.63-21.54 9

Powered by Capital Market - Live News